TITILOPE FASIPE to Female
This is a "connection" page, showing publications TITILOPE FASIPE has written about Female.
Connection Strength
0.080
-
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single-center case series. Pediatr Blood Cancer. 2024 Aug; 71(8):e31061.
Score: 0.026
-
Clinical Practice Patterns in Sickle Cell Disease Treatment: Disease-modifying and Potentially Curative Therapies. J Pediatr Hematol Oncol. 2024 07 01; 46(5):e277-e283.
Score: 0.026
-
Risk factors and co-morbidities in adolescent thromboembolism are different than those in younger children. Thromb Res. 2016 May; 141:178-82.
Score: 0.007
-
Splenic complications in pediatric sickle cell disease: A retrospective cohort review. Pediatr Blood Cancer. 2024 Oct; 71(10):e31219.
Score: 0.007
-
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease. Am J Hematol. 2020 09; 95(9):E242-E244.
Score: 0.005
-
Perspective: Sistas In Science - Cracking the Glass Ceiling. Ethn Dis. 2018; 28(4):575-578.
Score: 0.004
-
50 Years Ago in The Journal of Pediatrics: Familial Granulocytopenia and Associated Immunoglobulin Abnormality: Report of 3 Cases in Young Brothers. J Pediatr. 2018 03; 194:39.
Score: 0.004